Pyxis Oncology, Inc. Common Stock
Symbol: PYXS (NASDAQ)
3.38
▲ (0.90%) 0.030
Company Description:
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Key Stats
- Today's Open: $3.45
- Today's High: $3.565
- Today's Low: $3.27
- Today's Volume: 569.71K
- Yesterday Close: $3.35
- Yesterday High: $3.82
- Yesterday Low: $3.34
- Yesterday Volume: 688.96K
- Last Min Volume: 10
- Last Min High: $3.38
- Last Min Low: $3.38
- Last Min VWAP: $3.38
Company Profile
- Name: Pyxis Oncology, Inc. Common Stock
- Website: https://www.pyxisoncology.com
- Listed Date: 2021-10-08
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001782223
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $207.76M
- Round Lot: 100
- Outstanding Shares: 62.02M
- Asset Type: CS
RECENT FILINGS FOR PYXS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | SCHEDULE 13G/A | View |
| 2025-09-23 | SCHEDULE 13G | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-04 | 8-K | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-03 | 8-K | View |
| 2025-07-01 | SCHEDULE 13G | View |
| 2025-06-18 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-06 | SCHEDULE 13G/A | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-04-21 | 144 | View |
| 2025-04-17 | 144 | View |
| 2025-04-14 | 144 | View |
| 2025-04-02 | SCHEDULE 13D/A | View |
| 2025-04-02 | 4 | View |
| 2025-04-02 | 4 | View |
Latest News on PYXS